Laurus Labs receives approvals from USFDA

11 Mar 2019 Evaluate

Laurus Labs has received a final approval from the United States Food and Drug Administration (USFDA) for Hydroxychloroquine Tablets 200 mg.

In another development, the Company also received a tentative approval for an ANDA for ADL (Abacavir, Dolutegravir, and Lamivudine) Tablets 600 mg/50 mg/300 mg from USFDA.

The products will be commercialized from Laurus' manufacturing site located at Atchutapuram, Visakhapatnam.

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

1012.65 -5.55 (-0.55%)
04-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1818.60
Dr. Reddys Lab 1277.00
Cipla 1521.20
Zydus Lifesciences 935.20
Lupin 2091.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×